- CSR Summary Not Yet Available
- NCT02295865
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameToreforantProduct NameN/ATherapeutic AreaImmune System DiseasesEnrollment62% FemaleN/A% WhiteN/A
Product ClassHistamine receptor antagonistSponsor Protocol Number38518168PSO2001Data PartnerJohnson & JohnsonCondition StudiedPsoriasisMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Clinical Study Report Available